Institutional & Family Asset Management »

Miragen Therapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $392 18 21.78
2023-09-30 $275 18 15.33
2023-06-30 $238 10 23.80
2023-03-31 $254 10 25.40

More positions owned by Institutional & Family Asset Management

Listed Fd Tr Core Alt Fd (CCOR)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Institutional & Family Asset Management

Top funds holding Miragen Therapeutics

Paradigm Biocapital Advisors
VR Adviser
Vanguard Group
Maverick Capital
Alliancebernstein
Commodore Capital
Perceptive Advisors
Vivo Capital
Fairmount Funds Management
Yiheng Capital
Citadel Advisors
Tang Capital Management
Octagon Capital Advisors
Kynam Capital Management
Logos Global Management

View all funds holding Miragen Therapeutics